FIGURE

Figure 3

ID

ZDB-FIG-210707-39

Publication

Ma et al., 2021 - Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors

Other Figures

All Figure Page

Back to All Figure Page

Figure 3

OD29 antagonizes VEGF-induced pERK MAP kinase in HUVECs. (A–C) Western blot analysis of dose-dependent effects of small molecule VEGFR kinase inhibitor Axitinib (A), OD16 (B), OD29 (C), or vehicle control (DMSO) on VEGF (40 ng/mL)-induced VEGFR and ERK MAP kinase phosphorylation in HUVECs. (D) Quantification of the Western blot analysis of VEGF-induced p-ERK MAP kinase. Tubulin was used as a loading control. The results from three biologically independent Western blot experiments were integrated. The results are expressed as mean ± SD. (E,F) RT-qPCR analysis of the effects of Axitinib, OD16, OD29 (0.5 µM), or vehicle control (DMSO) on VEGF (40 ng/mL)-induced DLL4 (E) and NR4 A (F) mRNA expression in HUVECs. Results from three biologically independent experiments are shown as mean ± SD. * p < 0.05, ** p < 0.005, *** p < 0.001. NS, not significant. Complete Western Blot images of subfigures (A–C) are available in Figure S10.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers